Rego EM - Search Results

1

Reciprocal products of chromosomal translocations in human cancer pathogenesis: key players or innocent bystanders?

Rego EM, Pandolfi PP. Rego EM, et al. Trends Mol Med. 2002 Aug;8(8):396-405. doi: 10.1016/s1471-4914(02)02384-5. Trends Mol Med. 2002. PMID: 12127726 Review.

2

In vivo analysis of the role of aberrant histone deacetylase recruitment and RAR alpha blockade in the pathogenesis of acute promyelocytic leukemia.

Matsushita H, Scaglioni PP, Bhaumik M, Rego EM, Cai LF, Majid SM, Miyachi H, Kakizuka A, Miller WH Jr, Pandolfi PP. Matsushita H, et al. Among authors: rego em. J Exp Med. 2006 Apr 17;203(4):821-8. doi: 10.1084/jem.20050616. Epub 2006 Mar 20. J Exp Med. 2006. PMID: 16549595 Free PMC article.

3

Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins.

Rego EM, He LZ, Warrell RP Jr, Wang ZG, Pandolfi PP. Rego EM, et al. Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10173-8. doi: 10.1073/pnas.180290497. Proc Natl Acad Sci U S A. 2000. PMID: 10954752 Free PMC article.

4

Two critical hits for promyelocytic leukemia.

He LZ, Bhaumik M, Tribioli C, Rego EM, Ivins S, Zelent A, Pandolfi PP. He LZ, et al. Among authors: rego em. Mol Cell. 2000 Nov;6(5):1131-41. doi: 10.1016/s1097-2765(00)00111-8. Mol Cell. 2000. PMID: 11106752 Free article.

5

Analysis of the molecular genetics of acute promyelocytic leukemia in mouse models.

Rego EM, Pandolfi PP. Rego EM, et al. Semin Hematol. 2001 Jan;38(1):54-70. doi: 10.1016/s0037-1963(01)90006-x. Semin Hematol. 2001. PMID: 11172540 Review.

6

Role of promyelocytic leukemia (PML) protein in tumor suppression.

Rego EM, Wang ZG, Peruzzi D, He LZ, Cordon-Cardo C, Pandolfi PP. Rego EM, et al. J Exp Med. 2001 Feb 19;193(4):521-29. doi: 10.1084/jem.193.4.521. J Exp Med. 2001. PMID: 11181703 Free PMC article.

7

Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR alpha, PLZF/RAR alpha or NPM/RAR alpha.

Rego EM, Ruggero D, Tribioli C, Cattoretti G, Kogan S, Redner RL, Pandolfi PP. Rego EM, et al. Oncogene. 2006 Mar 23;25(13):1974-9. doi: 10.1038/sj.onc.1209216. Oncogene. 2006. PMID: 16331271

8

Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer.

Wei S, Kozono S, Kats L, Nechama M, Li W, Guarnerio J, Luo M, You MH, Yao Y, Kondo A, Hu H, Bozkurt G, Moerke NJ, Cao S, Reschke M, Chen CH, Rego EM, Lo-Coco F, Cantley LC, Lee TH, Wu H, Zhang Y, Pandolfi PP, Zhou XZ, Lu KP. Wei S, et al. Among authors: rego em. Nat Med. 2015 May;21(5):457-66. doi: 10.1038/nm.3839. Epub 2015 Apr 13. Nat Med. 2015. PMID: 25849135 Free PMC article.

9

Myeloid leukemia with promyelocytic features in transgenic mice expressing hCG-NuMA-RARalpha.

Sukhai MA, Wu X, Xuan Y, Zhang T, Reis PP, Dubé K, Rego EM, Bhaumik M, Bailey DJ, Wells RA, Kamel-Reid S, Pandolfi PP. Sukhai MA, et al. Among authors: rego em. Oncogene. 2004 Jan 22;23(3):665-78. doi: 10.1038/sj.onc.1207073. Oncogene. 2004. PMID: 14737102

10

(+)α-Tocopheryl succinate inhibits the mitochondrial respiratory chain complex I and is as effective as arsenic trioxide or ATRA against acute promyelocytic leukemia in vivo.

dos Santos GA, Abreu e Lima RS, Pestana CR, Lima AS, Scheucher PS, Thomé CH, Gimenes-Teixeira HL, Santana-Lemos BA, Lucena-Araujo AR, Rodrigues FP, Nasr R, Uyemura SA, Falcão RP, de Thé H, Pandolfi PP, Curti C, Rego EM. dos Santos GA, et al. Among authors: rego em. Leukemia. 2012 Mar;26(3):451-60. doi: 10.1038/leu.2011.216. Epub 2011 Aug 26. Leukemia. 2012. PMID: 21869839

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

198 results

Search Page